In The NewsView All
Regenstrief Vice President for Data and Analytics, Shaun Grannis, M.D., M.S., discussed the latest on monkeypox and how health and medical professionals are better at detecting, tracking, and understanding where monkeypox is, and how to mitigate the spread.
Regenstrief Vice President for Data and Analytics, Shaun Grannis, M.D.,...Read More
‘Memory loss is not normal aging’ — Regenstrief scientist highlights challenges of living with dementia
Regenstrief Institute Research Scientist NiCole Keith, PhD, addressed the many...Read More
- The Latest
The future of care
Precision medicine is a new and fascinating field of study and practice, combining prevention and treatment strategies. This field takes individual patient variables into account, including environmental factors, lifestyle, and even genetics. This emerging and revolutionary approach to care has the potential to greatly enrich the amount of data available on a single patient, and to leverage this data to improve quality of care and patient outcomes.
With the support of an award from the U.S. Department of Veterans Affairs, Regenstrief is at the forefront of this exciting field, particularly with the Precision Monitoring (PRIS-M) program. This program includes projects across multiple sites conducted by researcher clinicians at the Institute and with the Richard L. Roudebush VA Medical Center. Research takes place in diverse care environments, including emergency, inpatient, and outpatient settings.
Related News & Stories
Release first published by IU School of Medicine. DEGAS Study adds deep learning transfer to Seurat approach, creates identification of disease risk Indiana University School of...
Regenstrief Research Scientist Jennifer K. Maratt, M.D., M.S., co-authored a commentary in Gastroenterology about the benefits of gene-specific surveillance colonoscopy strategies for Lynch Syndrome, an inherited...
New prediction models for colon cancer and advanced precancerous polyps are easy to use clinical and public health tools
Researchers have created novel scoring tools for predicting actual risk of colon cancer and advanced precancerous polyps for patients at average risk for the disease. The...
Dr. Kun Huang (left) and Dr. Jie Zang (right) Novel multi-omics data analysis AI framework outperforms existing methods Genomics, proteomics, metabolomics, transcriptomics — rapid advances in...
Regenstrief Institute and Indiana University School of Medicine research scientist Kun Huang, PhD, is leading a team as part of the Indiana University Alzheimer’s disease drug...
Regenstrief, IU School of Medicine researchers collaborate with scientist quarantined in China during COVID-19 outbreak
Putting together research for publication can be a challenging and time-consuming process, heightened even further because of the current COVID-19 situation, during which non-essential labs have...
Colonoscopy shouldn’t be automatic for patients after an episode of diverticulitis An editorial challenges physicians and the U.S. healthcare system to reconsider the current “one size...
Patients with chronic diseases such as breast cancer or colorectal cancer often experience fatigue, pain, depression and other symptoms which can lead to distress and functional...